Medcell Pharma — Ondansetron Exporter Profile
Indian Pharmaceutical Exporter · #15 for Ondansetron · $1.3M export value · DGFT Verified
Medcell Pharma is the #15 Indian exporter of Ondansetron with $1.3M in export value and 32 verified shipments. Medcell Pharma holds a 1.1% market share in Ondansetron exports across 3 countries. The company exports 6 pharmaceutical products worth $7.5M across 4 therapeutic categories.
Medcell Pharma — Ondansetron Export Profile: Buyers & Destinations
Where Does Medcell Pharma Export Ondansetron?
| Country | Value | Shipments | Share |
|---|---|---|---|
| TURKEY | $128.9K | 7 | 45.6% |
| IRAQ | $90.6K | 5 | 32.0% |
| AFGHANISTAN | $63.2K | 21 | 22.4% |
Medcell Pharma exports Ondansetron to 3 countries. The largest destination is TURKEY accounting for 45.6% of Medcell Pharma's Ondansetron shipments, followed by IRAQ (32.0%) and AFGHANISTAN (22.4%). These destinations reflect Medcell Pharma's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ondansetron from Medcell Pharma?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| SEA GOLD PHARMA | TURKEY | $106.7K | 3 |
| NABAA AL-WARKA SCIENTIFIC BUREAU | IRAQ | $53.9K | 3 |
| MILAD MUSAWAR TRADE COMPANY | AFGHANISTAN | $24.0K | 8 |
| NABAA AL-WARKA SCIENTIFIC BUREAU5 | IRAQ | $20.4K | 1 |
| OSCAR GLOBAL LOGISTICS CUSTOMS | TURKEY | $19.0K | 3 |
| IMS LOJISTIK ULUSLARARASI YALINAYAK MAHALLESI | IRAQ | $16.2K | 1 |
| ABDULLAH WALI RAHMAN LTD. | AFGHANISTAN | $12.4K | 2 |
| DELPHA PHARMA LTD | AFGHANISTAN | $6.4K | 2 |
| BORADARAN MAYAR LTD. | AFGHANISTAN | $5.8K | 2 |
| FAQIR ZAMAN LTD. | AFGHANISTAN | $5.0K | 2 |
Medcell Pharma supplies Ondansetron to 16 buyers globally. The largest buyer is SEA GOLD PHARMA (TURKEY), followed by NABAA AL-WARKA SCIENTIFIC BUREAU (IRAQ) and MILAD MUSAWAR TRADE COMPANY (AFGHANISTAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ondansetron Export Value and How Much Does Medcell Pharma Contribute?
India exported $100.2M worth of Ondansetron through 8,469 shipments from 537 suppliers to 157 countries, serving 1,636 buyers globally. Medcell Pharma contributes $1.3M to this total, accounting for 1.1% of India's Ondansetron exports. Medcell Pharma ships Ondansetron to 3 countries through 16 buyers.
What Is the Average Shipment Value for Medcell Pharma's Ondansetron Exports?
Medcell Pharma's average Ondansetron shipment value is $40.6K per consignment, based on 32 shipments totaling $1.3M. The largest destination is TURKEY (45.6% of Medcell Pharma's Ondansetron exports).
How Does Medcell Pharma Compare to Other Indian Ondansetron Exporters?
Medcell Pharma ranks #15 among 537 Indian Ondansetron exporters with a 1.1% market share. The top 3 exporters are AUROBINDO PHARMA LTD ($31.2M), GLENMARK PHARMACEUTICALS LIMITED ($15.9M), BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED ($10.8M). Medcell Pharma processed 32 shipments to 3 destination countries.
What Ondansetron Formulations Does Medcell Pharma Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| VOMIRID (ONDANSETRON INJECTION BP 8MG/4M | $106.7K | 3 |
| PHARMACEUTICAL MEDICINES : VOMIRID (ONDANSETRON TABLETS USP 8MG)EACH UNCOATED DISPERSIBLE TABLET CONTAINS:ONDANSETRON HY | $23.4K | 1 |
| VOMIRID INJECTION (ONDANSETRON INJECTIONBP 8MG/4ML) EACH 4ML CONTAINS,(OTHER DETAILS AS PER INV & PKG LIST) | $20.4K | 1 |
| VOMIRID INJECTION ONDANSETRON INJECTIONBP 8MG/4MLCOM:EACH 4ML CON:ONDANSETRONHYDROCHLORIDE DIHY.O/D AS PER INV&PL | $16.2K | 1 |
| VOMIRID INJECTION ONDANSETRON INJECTIONBP 8MG/4ML COMPOSITION:BATCH NO:A23ET006A23ET007 | $15.3K | 1 |
| VOMIRID INJECTION ONDANSETRON INJECTIONBP 8MG/4ML COMPOSITION:BATCH NO:A23ET004A23ET005 | $15.3K | 1 |
| PHARMACEUTICAL MEDICINES:VOMIRID (ONDANSETRON INJECTION USP 8MG/4ML) CAS NO.: 103639-04-9 | $11.4K | 1 |
| ONDASIS (ONDANSETRON INJECTION USP 4MG/2ML) EACH ML CONTAINS:ONDANSETRON HYDROCHLORIDE USP EQ. O/D AS PER INV&PL | $7.8K | 2 |
| ONDASIS DROPS (ONDANSETRON ORAL SOLUTIONUSP 4MG/5ML)EACH 5ML CONTAINS:ONDANSETRON HYDROCHLORIDE USP - O/D AS PER INV&PL | $7.7K | 2 |
| DE-VOMID(ONDANSETRON INJECTION BP 8MG/4M | $6.9K | 1 |
Medcell Pharma exports 29 distinct Ondansetron formulations including tablets, capsules, syrups, and combination drugs. The top formulation is VOMIRID (ONDANSETRON INJECTION BP 8MG/4M with 3 shipments worth $106.7K.
How Does Medcell Pharma Compare to Nearest Ondansetron Exporters?
Exporters ranked immediately above and below #15 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 13 | DR REDDYS LABORATORIES LIMITED | $1.9M | 58 | 3 | $33.4K |
| 14 | NATCO PHARMA LIMITED | $1.6M | 90 | 3 | $18.0K |
| 15 | MEDCELL PHARMA ★ | $1.3M | 32 | 3 | $40.6K |
| 8 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $750.0K | 15 | 3 | $50.0K |
Medcell Pharma ranks #15 among 537 Indian Ondansetron exporters. Average shipment value of $40.6K compared to the market average of $186.5K. The closest competitors by value are DR REDDYS LABORATORIES LIMITED and NATCO PHARMA LIMITED.
Which Indian Ports Ship Ondansetron Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 1,058 | 12.5% |
| NHAVA SHEVA SEA (INNSA1) | 1,026 | 12.1% |
| SAHAR AIR | 993 | 11.7% |
| HYDERABAD ICD (INSNF6) | 509 | 6.0% |
| HYDERABAD ICD | 448 | 5.3% |
| JNPT/ NHAVA SHEVA SEA | 343 | 4.1% |
| DELHI AIR CARGO ACC (INDEL4) | 265 | 3.1% |
| AHEMDABAD AIR ACC (INAMD4) | 224 | 2.6% |
About Medcell Pharma
Medcell Pharma exports 6 products worth $7.5M. Beyond Ondansetron, top products include Ceftriaxone, Ofloxacin, Levofloxacin, Amikacin, Nicotine. View the complete Medcell Pharma profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ondansetron — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ondansetron shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Medcell Pharma matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 33 individual customs records matching Medcell Pharma exporting Ondansetron, covering 29 formulations to 3 countries via 16 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 157+ countries, 1,636+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ondansetron Export Data from Medcell Pharma
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Medcell Pharma's Ondansetron exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Medcell Pharma
Full Company Profile →
6 products · $7.5M total trade · 4 categories
Ondansetron Stats
Company Overview
Top Products by Medcell Pharma
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Medcell Pharma.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ondansetron. For current shipment-level data, contact TransData Nexus.